To evaluate whether the heterogeneity of Trop2 expression in tumors could be visualized via Trop2-targeted PET/CT, we analyzed 68Ga-MY6349 tumor uptake in different lesions within the same patient (Figure 3C). Here, TACSTD2 is linked to neoplasm.